Skip to main content
. 2020 May 12;9(5):1431. doi: 10.3390/jcm9051431

Table 3.

Antibiogram patterns of Elizabethkingia spp. infection.

Antibiotics Total
(n = 210)
Survivor
(n = 157)
Non-Survivor
(n = 53)
p-Value
Elizabethkingia (%) 0.513
    E. meningoseptica 132 (62.9) 94 (59.9) 38 (71.7) 0.123
    E. anophelis 38 (18.1) 30 (19.1) 8 (15.1) 0.512
    E. miricola 15 (7.1) 12 (7.6) 3 (5.7) 0.765
    Species not identified 25 (11.9) 21 (13.4) 4 (7.5) 0.257
Susceptibility, yes (%)
      Minocycline 186 (89.4) 138 (89.0) 48 (90.6) 0.805
      Cotrimoxazole 150 (72.1) 116 (77.3) 34 (64.2) 0.157
      Anti-pseudomonal penicillins 18 (8.7) 13 (8.4) 5 (9.4) 0.782
      Moxifloxacin 103 (84.4) 76 (82.6) 27 (90.0) 0.400
      Rifampin 92 (76.0) 73 (80.2) 19 (63.3) 0.060
      Vancomycin 134 (96.4) 102 (95.3) 32 (23.9) 0.589
MIC (ug/mL)
      Moxifloxacin (range: 0.012 to >32) 2.0 ± 5.7 2.1 ± 5.7 1.5 ± 5.9 0.636
      Rifampin (range: 0.008 to >32) 7.5 ± 13.0 6.0 ± 11.7 11.9 ± 15.6 0.031
      Vancomycin (range: 0.050 to >256) 12.2 ± 39.4 14.6 ± 45.1 4.6 ± 3.1 0.230

MIC, minimal inhibitory concentration. Continuous variables are shown as the mean ± SD (standard deviation) and categorical variables, as numbers (percentage).